Sunshine Biopharma Inc. Common Stock (NASDAQ: SBFM) last traded at $0.243, up 2.84% on the session. The quote above updates while this page is open; the figures below are drawn from Sunshine Biopharma Inc. Common Stock’s own filings and are restated only when a new one is published.
Sunshine Biopharma Inc. Common Stock trades on NASDAQ under the ticker SBFM. Its market capitalisation is $942,192.891.
Valuation measures for Sunshine Biopharma Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $942.2K |
|---|---|
| Enterprise value | -$6.71M |
| P/E ratio | 0.16 |
| Price / sales | 0.03 |
| Price / book | 0.03 |
| Beta | 0.66 |
Trailing-twelve-month figures tagged in Sunshine Biopharma Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $35.35M |
|---|---|
| Net income (TTM) | -$5.83M |
| EPS (TTM) | $1.54 |
| Gross margin | 30.30% |
| Operating margin | -16.65% |
| Return on equity | -21.18% |
| Cash | $13.75M |
Range and volume for SBFM over the past 52 weeks.
| 52-week high | $24.30 |
|---|---|
| 52-week low | $0.212 |
| Volume | 1.69M |
| Average volume | 5.42M |
| Previous close | $0.236 |
Invest a chosen dollar amount in Sunshine Biopharma Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell SBFM.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.